Wei Jiang

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Nlrp Inflammasome

Top Venues

Science (New York, N.Y.)

EMBO molecular medicine

Nature cell biology

Nature immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Yi Huang, Wei Jiang, Rongbin Zhou
DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways. Nature reviews. Immunology (2024)
Yueli Xu, Jiaxian Yan, Ye Tao, Xiaojun Qian, Chi Zhang, Libei Yin, Pengying Gu, Yu-Chen Liu, Yueyin Pan, Renhong Tang, Wei Jiang, Rongbin Zhou
Pituitary hormone α-MSH promotes tumor-induced myelopoiesis and immunosuppression. Science (New York, N.Y.) 377 (6610) (2022)
Yi Huang, Huanyu Wang, Yize Hao, Hualong Lin, Menghao Dong, Jin Ye, Lei Song, Yunzhi Wang, Qingqing Li, Benjie Shan, Yizhou Jiang, Hongqi Li, Zhiming Shao, Guido Kroemer, Huafeng Zhang, Li Bai, Tengchuan Jin, Chao Wang, Yuting Ma, Yongping Cai, Chen Ding, Suling Liu, Yue-Yin Pan, Wei Jiang, Rongbin Zhou
Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity. Nature cell biology 22 (6) (2020)
Lei Liu, Tao Gong, Wanyin Tao, Bolong Lin, Cong Li, Xuesen Zheng, Shu Zhu, Wei Jiang, Rongbin Zhou
Commensal viruses maintain intestinal intraepithelial lymphocytes via noncanonical RIG-I signaling. Nature immunology 20 (12) (2019)
Yi Huang, Hua Jiang, Yun Chen, Xiaqiong Wang, Yanqing Yang, Jinhui Tao, Xianming Deng, Gaolin Liang, Huafeng Zhang, Wei Jiang, Rongbin Zhou
Tranilast directly targets NLRP3 to treat inflammasome-driven diseases. EMBO molecular medicine 10 (4) (2019)